Concepedia

Rebekah Gould

RG

14

Publications

1.6K

Citations

12

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Yale Cancer Center

University of California, San Francisco

Yale University

Silesian University of Technology

Rebekah Gould is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2013–2023

14

Publications

14

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

W. Fraser Symmans, Caimiao Wei, Rebekah Gould et al. · Journal of Clinical Oncology · 2017 · 687 citations · Full text

, , +14

SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

Bruno V. Sinn, Chunxiao Fu, Rosanna Lau et al. · npj Breast Cancer · 2019 · 350 citations · Full text

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy

S.J. Luen, Roberto Salgado, Maria Vittoria Dieci et al. · Annals of Oncology · 2018 · 196 citations · Full text

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

Florentia Peintinger, Bruno V. Sinn, Christos Hatzis et al. · Modern Pathology · 2015 · 112 citations · Full text

, , +10

Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer

Christos Hatzis, W. Fraser Symmans, Ya Zhang et al. · Clinical Cancer Research · 2015 · 63 citations

Rows per page

1–5 of 14